POPULARITY
23 episodes with EOM
6 episodes with EOM
2 episodes with EOM
2 episodes with EOM
2 episodes with EOM
5 episodes with EOM
2 episodes with EOM
3 episodes with EOM
4 episodes with EOM
It's “Nvidia Day!” The Big Dog in the Tall Grass for AI reports earnings after the closing bell today. Lance Roberts & Danny Ratliff delve into the anticipation surrounding Nvidia's upcoming earnings report, set to be released after today's market close. We'll explore market expectations, potential impacts on NVDA stock, and the broader implications for the AI and semiconductor sectors. Also a discussion about the inimitable Mrs. Roberts, and the profound changes AI is poised to wrought on global industries. Is the 4% Rule dead or just being updated? Lance bemoans the bots in our X and YouTube channels, and he and Danny review the changes afoot in advisors' recommendations for retirement savings drawdowns. SEG-1: EOM & Shifting Sentiment SEG-2a: Lance' Wife is Scary SEG-2b: Is AI the Next Leg of Industrial Revolution? SEG-3a: Retirement Income Empowerment teaser SEG-3b: Death of the 4% Rule? SEG-4a: Twitter Bots & Chatrooms SEG-4b: Changing the 4% Rule Hosted by RIA Advisors Chief Investment Strategist Lance Roberts, CIO, w Senior Financial Advisor Danny Ratliff, CFP Produced by Brent Clanton, Executive Producer ------- Watch today's video on YouTube: https://www.youtube.com/watch?v=WWSQGN1zFrg&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1 ------- Articles mention in this show: "The Anchoring Problem And How To Solve It" https://realinvestmentadvice.com/resources/blog/the-anchoring-problem-and-how-to-solve-it/ "Trump Tariffs Are Inflationary Claim The Experts" https://realinvestmentadvice.com/resources/blog/trump-tariffs-are-inflationary-claim-the-experts/ ------- The latest installment of our new feature, Before the Bell, "What is the Risk to Nvidia?" is here: https://www.youtube.com/watch?v=6KJCZut3qwU&list=PLwNgo56zE4RAbkqxgdj-8GOvjZTp9_Zlz&index=1 ------- Our previous show is here: "The Anchoring Problem & How to Solve It" https://www.youtube.com/watch?v=6t41x9fsYv8&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=4s ------- Register for our next in-person event, "Retirement Income Empowerment Workshop," June 14, 2025: https://tracking.realinvestmentadvice.com/l/1052953/2025-05-08/ysxr ------- Get more info & commentary: https://realinvestmentadvice.com/newsletter/ -------- SUBSCRIBE to The Real Investment Show here: http://www.youtube.com/c/TheRealInvestmentShow -------- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN -------- Subscribe to SimpleVisor: https://www.simplevisor.com/register-new -------- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #NvidiaDay #NVDA #NvidiaStock #TechStocks #StockMarketNews #MoneyFlows #Nvidia #TrumpTariffs #Inflation #MarketCorrection #MarketPullback #BuyTheDip #ReduceRisk #RaiseCash #MarketConsolidation #20DMA #50DMA #100DMA #200DMA #AnchoringBias #BehavioralFinance #CognitiveBiases #InvestmentPsychology #SmartInvesting #InvestingAdvice #Money #Investing
What is EOM reporting that closes after the end of the month? Why do people still do this and why is this no longer a good solution? Listen to find out a modern data and reporting way of doing things that works much better.
En lo último en salud y fitness edición de abril 2025, damos un paseo por las últimas tendencias, investigaciones y noticias en el mundo de la salud y el fitness.En este episodio hablaremos de temas desde cómo la cafeína afecta tu rendimiento (y por qué a veces parece que ya no funciona), hasta la última información sobre los suplementos de omega-3 para el cuidado de tus ojos. También veremos datos nuevos sobre los monitores de glucosa que te harán repensar algunas cosas, y pondremos sobre la mesa la verdad sobre los medicamentos GLP-1 y su efecto en tu músculo.Atajos del episodio: 02:56 - ¿Tomar cafeína todos los días te vuelve inmune a sus efectos para el ejercicio?106:47 - ¿Usas lágrimas artificiales? Mejor dale a tus ojos lo que realmente necesitan211:50 - La glucosa no es tan predecible como pensabas318:16 - GLP-1 y pérdida de peso: ¿también estás perdiendo músculo?423:19 - Más omega-3 y omega-6, menos grasa corporal (sí, leíste bien: omega-6 también)5Referencias: 1. Khodadadi, D., Azimi, F. & Moghanlou…, A. E. Habitual Caffeine Consumption and Training Status Affect the Ergogenicity of Acute Caffeine Intake on Exercise Performance. Sports … (2025).2. Hong, S., Woo, M., Eom, Y., Kim, H. K. & Yoon…, K. C. A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG …. Journal of Ocular … (2025).3. Hengist, A., Ong, J. A., McNeel, K., Guo, J. & Hall, K. D. Imprecision nutrition? Intraindividual variability of glucose responses to duplicate presented meals in adults without diabetes. The American Journal of … (2025).4. Beavers, K. M., Cortes, T. M., Foy, C. M. & Dinkla…, L. G LP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials. … (2025).5. Yang, Z. et al. Omega-3 and omega-6 fatty acids: Inverse association with body fat percentage and obesity risk. Nutrition Research (2025).
In this episode, The Crew discusses the first EoM batch for 2025 with the likes of Nami & Sanji and Usopp & Lilith, they also give their thoughts on what the Global Anniversary could be. Todd and Flame discuss the Dokkan 10th Anniversary and all that has been happening in the TCG Corner. For details about future uploads and if you want to keep up to date with the hosts on the show, please follow our social media; Good, Great, Perfect Socials: https://linktr.ee/GoodGreatPerfect ------------------------------------------------------------------------------------------------------------ Good, Great, Perfect Podcast discusses all things ONE PIECE Treasure Cruise and beyond, and we thank you for watching/listening to this podcast. GGP Crew: - Captain Papi Twitter: https://twitter.com/captainpapii - Toadskii Twitter: https://twitter.com/Toadskii - Nitemare Twitter: https://twitter.com/nitemarejp - Flamevious Twitter: https://twitter.com/Villainueva__ #OPTC #TreCru
It's the end of the month, and the determining day for the January Barometer is tomorrow. Markets knee-jerked all over the board following yesterday's Fed announcements to hold firm at current rates. Economic news was not encouraging, with export up, imports down, suggesting the economy is weaker than thought; labor and demand dynamics. There is a lot of speculative money pouring into markets; nobody is buying stocks anymore. It's all in options, which will end badly for many because it's very speculative. Lance recounts the latest reports from Magnificent-7 member companies; Michael explores data center dynamics, the DeepSeek effect of cheaper processing, and Tesla's big plans. An admonition to be careful about following headlines; the one thing China is good at: Stealing the work of others'. Lance's favorite day is Thursday; economic data is not good; what the Fed thinks now and commentary on Labor; What the Atlanta Fed said; trying to control inflation from the Executive Branch. How did DeepSeek do it? Michael preaches on the fallacy of Meme Coins, and why they're destroyers of wealth; the role of influencers. SEG-1: January Barometer & EOM; Nobody's buying Stocks Anymore SEG-2: MAG-7 Round up and Data Center Dynamics SEG-3: Cheat Meals & Fed News SEG-4a: How DeepSeek Did It SEG-4b: How Meme Coins Destroy Wealth Hosted by RIA Advisors Chief Investment Strategist Lance Roberts, CIO, w Portfolio Manager Michael Lebowitz, CFA Produced by Brent Clanton, Executive Producer ------- Watch today's show video here: https://www.youtube.com/watch?v=XH68Ot3zIsQ&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=5s ------- Articles mentioned in this report: "Meme Coins Do Not Create Wealth: They Destroy It" https://realinvestmentadvice.com/resources/blog/meme-coins-do-not-create-wealth-they-destroy-it/ "DeepSeek DeepSinks Bullish Exuberance" https://realinvestmentadvice.com/resources/blog/deepseek-deepsinks-bullish-exuberance/ "Strategic Crypto Stockpile And Political Uncertainty" https://realinvestmentadvice.com/resources/blog/strategic-crypto-stockpile-and-political-uncertainty/ "Inauguration Sends Confidence Surging Higher" https://realinvestmentadvice.com/resources/blog/use-drone-mentality-to-financial-success/ ------- The latest installment of our new feature, Before the Bell, "Why Options Data is Off the Hook," is here: https://www.youtube.com/watch?v=Qc1OMnQvUgI&list=PLwNgo56zE4RAbkqxgdj-8GOvjZTp9_Zlz&index=1 ------- Our previous show is here: "Watching the Mega-Cap Earnings Parade" https://www.youtube.com/watch?v=HHyXhn76ta4&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=2 ------- Get more info & commentary: https://realinvestmentadvice.com/newsletter/ -------- SUBSCRIBE to The Real Investment Show here: http://www.youtube.com/c/TheRealInvestmentShow -------- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN -------- Subscribe to SimpleVisor: https://www.simplevisor.com/register-new -------- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #FederalReserve #InterestRates #FedPolicy #Options #CallOptions #PutOptions #SpeculativeMoney#EarningsSeason #StockMarketNews #BigTechEarnings #InvestingTrends #FinancialMarkets #MoneyFlows #PriceSupport #USDollar #DollarStrength #DollarWeakness #DeepSeek #AI #TechnologyStocks #China #Nvidia #Apple #PortfolioRisk #PortfolioDiversification #Chips #Technology #FinanceTips #InvestmentStrategies #MarketAnalysis #EconomicOutlook#InvestingAdvice #Money #Investing
Hablamos con el periodista Fernando Arancón, director de El Orden Mundial (EOM) y presentador de 'No es el fin del mundo', el podcast semanal de EOM para entender qué pasa en el mundo.
En este programa especial de fin de año respondemos a todas las preguntas que nos han dejado los oyentes, desde el trabajo que hacemos en EOM a dudas y curiosidades sobre el mundo: ¿Por qué en Reino Unido dicen laborismo en vez de socialdemocracia? ¿Qué es la Orden de Malta? ¿Cuál es la diferencia entre alto al fuego y armisticio? David Gómez, Alba Leiva y Fernando Arancón contestan a estas y más preguntas en este episodio especial de "No es el fin del mundo".
Hey everybody, this is Pete Worrell from Bigelow, and I'd like to welcome you to this episode of the Positive Enterprise Value Podcast. In this podcast we interview seasoned, successful, high-performing Entrepreneur Owner-Managers (EOMs), people who own and lead significant enterprises in a variety of domains and niches across the country. Have you ever noticed that some private enterprises successfully transitioned through evolutions and revolutions in leadership, management and even ownership? Some ending up with a terrific new majority owner, the EOM moving gracefully into the next interesting and rewarding chapter in their lives, surrounded by friends with their positive legacy intact, and their independence powered or fueled by the fortune they just realized. While others' outcomes look more like a train wreck. Is it luck or is it more than luck? We think it's more than luck. In this episode I have the fun of interviewing Michael Kiolbassa. Michael and I have known each other for almost 10 years. He is the CEO of Kiolbassa Provision Company (link: https://kiolbassa.com/) in San Antonio, TX where they're celebrating their 75th year in business. It was Michael's grandfather and then his father, who shepherded the business, which was largely a fresh meat slaughtering house until Michael came along. And now, of course, it is widely known as one of the highest quality sausage and provision companies in the country. Michael talks us through when he joined the business. Some of the challenges he had both in the business and with his family (Michael's father and uncle had owned the business until then, so Michale had both his own immediate family as well as cousins in the business.) He shares some of his hopes and dreams to become a national business and some of the adversity he encountered along the way. Michael is extremely articulate and candid and vulnerable about some of the challenges, failures and learnings; I know you will love this episode because I surely did. Without further ado, join me in listening to Michael Kiolbassa.
In deze aflevering interviewt Annette van Soest Europees aanklager Miranda de Meijer van het Europees Openbaar Ministerie. Criminele netwerken verleggen hun verdienmodel van drugs- en wapenhandel naar complexe financiële fraudeconstructies zoals btw-carrouselfraude, ziet zij.
In deze aflevering interviewt Annette van Soest Europees aanklager Miranda de Meijer van het Europees Openbaar Ministerie. Criminele netwerken verleggen hun verdienmodel van drugs- en wapenhandel naar complexe financiële fraudeconstructies zoals btw-carrouselfraude, ziet zij.
In today's throwback episode we sit down with nutrition and fitness expert Thomas DeLauer to unpack game-changing strategies for muscle growth and recovery. We dive deep into the science behind taurine supplementation, strategic carbohydrate timing, and the real truth about fasted training that you need to know. Connect with Thomas: Instagram: https://www.instagram.com/thomasdelauer Never let momentum get to zero. Listen to the Jason Khalipa Podcast every Monday and Thursday on Apple Podcasts, Spotify, or YouTube. Follow Jason: https://instagram.com/jasonkhalipa?igshid=MzRlODBiNWFlZA== Follow TRAIN HARD: https://www.instagram.com/trainhard.fit/?hl=en Never Zero Newsletter: https://www.th.fit/ NCFIT Programming For Gym Owners: https://www.nc.fit/programming Philanthropy: https://avaskitchen.org/ 00:00 - The importance of communication with kids 01:45 - Kids understand more than adults think 05:16 - Listening deeply builds stronger relationships 06:58 - Coping differences in relationships explained 10:10 - How taurine boosts workouts and energy 12:04 - Top supplements for CrossFit and longevity 15:43 - Personal experiments spark better performance 17:26 - Joy and fulfillment from pursuing performance goals 20:51 - Thomas DeLauer's personal growth journey 22:27 - Using carbs for better sleep and keto balance 25:41 - Carbs after workouts help muscles recover 27:24 - How diet impacts training and evolves over time 30:49 - Benefits of watermelon for recovery workouts 32:21 - Fat-burning improvements with fasted workouts 35:22 - Moving from structured to intense workouts 36:54 - Overview of the Train Hard app programs 40:10 - EOM workouts for cardio and endurance gains 41:43 - Pacing strategies for better workouts and recovery 44:52 - Comparing Zone 2 cardio to high-intensity training 46:32 - Why tracking heart rate matters in exercise 49:30 - Breathing techniques for better Jiu-Jitsu performance 51:02 - Tackling aquatic training with breathing techniques 54:13 - Staying relaxed under stress improves performance 55:56 - Handling life's challenges by going with the flow 58:53 - Staying relaxed and focused during workouts 1:00:28 - Thomas DeLauer shares his marriage journey 1:03:42 - Bonding with loved ones over food and family 1:05:12 - How communication and independence strengthen relationships 1:08:39 - Parenting creates deeper love and stronger connections 1:10:13 - Supporting loved ones through health challenges 1:13:31 - Inspiring others by making health fun 1:14:58 - Where to find Thomas DeLauer's content
D*ick molds, blue chews, doing drugs with your family, being Jewish. Right here, right now, on EOM. IF YOU'RE READING THIS CLICK THIS LINK IT IS IMPORTANT: https://www.speakpipe.com/EachOthersMothers Produced by Mar | Recorded at HMC Studios IG @johanna.medranda @itchysnitchy --- Support this podcast: https://podcasters.spotify.com/pod/show/eachothersmotherspodcast/support
We're all feeling the intensity – so how can Feminine Wisdom support us to navigate through it? Well, it starts with taking a pause, putting on our “wise being glasses,” and then taking a deeper look at what is going on in the Field (the bigger collective world) and in our personal field (our own inner experiences, relationships and reality). This pause allows us to see what is real, what is needed, what the patterns are, and to find the wisdom to navigate the now and the next. In this episode, Christine and Jennifer explore how Feminine Wisdom can support us in intense times, to elevate and expand our consciousness, so that we can liberate ourselves from the stuff we just don't want to carry with us or create from anymore. The intention of our exploration is to give you perspectives and practices to prepare you for the now, and the next. Some of the wisdom models, practices and tools we'll work with in this episode are: Triangle of Transformation Sovereignty in the Swirl This is not that Co-Create from Momentum and Intention Be aware of the now and what's needed, AND keep the long game in mind. Put energy into both. Focus on your part and your design. If you are not clear, create space to get clear this year. EOE: Evidence of Elevation EOM: Evidence of Momentum Between now and the next episode, Christine and Jennifer invite you to contemplate the inquiry: What EOEs and EOMs am I seeing? Bonus invitation: SHARE this podcast with a friend, and invite them to play the EOE / EOM Game with you – share one EOE or EOM with each other every day. It's how we can all Stay Light together, in community – join us! Resources & Links: Morning Practice Guide Overwhelmed & Over It book - Read Section 2: Liberate Your Life Force Triangle of Transformation - video and model posted on the Feminine Wisdom Cafe What's next? Tune in to the 9-part Season of Light series, running now through the end of August - and invite a friend to join you! Remember to SHARE this podcast episode with at least one friend or colleague. Then invite them to play the EOE / EOM Game – find and share one EOE or EOM daily with each other. Notice how this simple act supports you in Staying Light! Ways to Connect: Join us in the Feminine Wisdom Cafe, a private online community Subscribe to Christine's Monthly Wisdom Letters Connect with Christine and Jennifer on LinkedIn Watch on YouTube
“You changed the business I sold you so you could underpay me!” ___ By deed P sold their shares in an online retail business to D.P was to receive $20M, some shares in D, and the Earn Out Amount (“EOM”): [3] According to the deed, the EOM was the Base EOM of $10M plus the Additional EOM: [6] The Additional EOM was the rounded difference between the Base EOM (I.e. $10M) and “Earnings”: [7] “Earnings” meant EBITDA over the relevant year. The deed contained a mechanism for D send a proposed Earnings calculation (as part of a P and L), for P to make a reply including setting out “Contested Matters”, for the parties to negotiate the contested matters in good faith, and for the matter to be referred to an expert if negotiations failed: [10] - [14] D sent a P and L suggesting Earnings were ~$6M (making the Additional EOM zero): [16] P sent a reply calculating Earnings at ~$15M (taking the Additional EOM to its maximum possible figure) and raising Contested Matters: [17] Following unsuccessful good faith negotiations, the matter was referred to an expert: [18] How was the expert to calculate Earnings?: [19] Cll 2.1 and 2.2 of the deed required Earnings to be calc'd disregarding revenues or expenses not part of the Co's ordinary business including: costs relating to the share sale, restructure costs, certain related party transactions, and the costs of kicking off any new business: [21] Cl 2.3 of the deed noted the parties' agreement that Earnings were to be calc'd as if the Co's business were run the same way post-purchase as it had been pre-purchase; and that D would not make big changes to the Co's business (or, if D did make big changes, the EOM would be normalised to exclude those changes' impact): [21] P sued, seeking declarations that the expert determine Earnings in accordance with all of the above. D resisted: [25] - [27] The Court found for the P: [28] The well-known principles regarding contractual interpretation were (respectfully) helpfully restated at [29] - [33] The Court noted the parties' explicit agreement on the mandatory language in Cl 2.3; that Earnings *must* be calculated that way: [48] - [50] The proper construction was found to be on that basis: [54] P's pressed for their Contested Matters to be referred to the expert.P said Earnings had to be adjusted due to D failing to implement a new website, leading to lower website traffic. The Court accepted this Contested Matter was appropriately dealt with by the expert: [63] - [77] Similarly: P's complaint regarding D's failure to implement P's logistics proposal was to be properly dealt with by the expert: [78] - [82] Again similarly: P's complaint that D's marketing efforts wrongly focussed on conversion rather than branding was properly dealt with by the expert: [83] - [86] The expert was required to value Earnings as P proposed, and to deal with P's Contested Matters: [87] ___ Please head to www.gravamen.com.au - that's my law firm!
This week is our second installment of our “hidden gems” theme, in which we bring you movies or shows that need to be seen by more people.In this episode, we discuss Ava Duvernay's “Origin” and Wim Wenders' “Perfect Days” with spoilers. Then we discuss Tae-hwa Eom's “Concrete Utopia” without spoilers since Susan and Cort hadn't seen it yet.Listen in to hear what we like about each film, why they are hidden gems, and what kind of impact the films had on us.-Original music by Garrett ThompsonFollow us on Instagram @GeekGirlSoupContinue the conversation on FacebookListen to Cort's podcast with Brad at PureFandom.comCheck out Susan's movie stats on Letterboxd Email your questions and comments to GeekGirlSoup@gmail.comGeek on!Next week: Apple TV+'s “STEVE! (martin).” Please do go watch! See you next time!
Nuestro poeta, Mario Obrero, ha decidido que "Lo que toca" hoy es hablar de poesía en un trayecto de tren Madrid-Barcelona. Después, en "El consulado" de Aitor Caminero, conversamos con la analista del portal El Orden Mundial (EOM) Alba Leiva sobre la actualidad política en la India, donde se celebran elecciones generales a partir del próximo jueves. Y ya es miércoles y seguimos descubriendo "La playlist de Maika Makovski". Esta semana, canciones primaverales: Here Comes The Sun (The Beatles), Spring Is Here (Nina Simone), I Can See Clearly Now (Johnny Nash), April In Paris (Ella Fitzgerald y Louis Armstrong), The River (Bruce Springsteen) y Un millón de primaveras (Vicente Fernández).Escuchar audio
Las teorías de las relaciones internacionales son las distintas corrientes de pensamiento dentro de la disciplina. Por un lado están las teorías clásicas: el realismo y el liberalismo o idealismo. Por otro lado, las teorías críticas: el marxismo, la teoría crítica, el poscolonialismo, el feminismo o el ecologismo. Pero, ¿por qué existen las teorías de las relaciones internacionales? ¿Qué defiende cada una? Fernando Arancón y Alba Leiva lo analizan en este EOM explica de “No es el fin del mundo”.
In this training, Jess is walking you through our unique EOM™ formula so you can create a scalable 6-figure (and beyond) coaching business… without having a big following, paying for expensive ads, or burning out from hours on 1:1 calls. Most struggling entrepreneurs think that creating a business will give them freedom, but that couldn't be farther from the truth. It's actually systems & structure in your business that gives you freedom. Listen in as Jess breaks down the entire business machine, to ensure you're no longer acting as the machine. Live attendance is highly encouraged, and there will be special bonuses for those who attend each of the trainings live! However, if you're NOT able to join us live, don't worry - there will be a replay available to you for a limited time, so you can watch at a time that works for you. As always, cheers to your evolution! Related Links Get Registered and Binge watch the entire event here: https://www.jessglazer.com/dbe-live-2024 About Jessica DeRose Jessica DeRose is an entrepreneur and business mentor, who helps coaches and service providers build online businesses. After leaving her 8-year career as an elementary school teacher and going on to doing multiple 7-figures in sales as an entrepreneur, Jess is here to unlock doors you didn't even know existed! Connect with Jess Instagram: @iamjessicaderose TikTok: @iamjessicaderose YouTube: Jessica DeRose
WE BACK (((AGAINLOL))) EOM is back and "mom"er than ever. Catch up with your fav, meet your new co-host, sit and relax for 30ish minutes while we take your ears on a journey. Season Bri of EOM now playing
Meet Jess Glazer-Derose Dog mom, fashion lover, launch queen, & digital marketing expertI started my online course business as a “cute side hustle” in 2012 while I was working full-time as an elementary school teacher. In 2017 I left my comfortable 9-5 to go all in on my coaching business and scaled to my first million in just 18 months. Since then, I've been dedicated to dissecting my process and creating a scalable & sustainable framework for clients like you. My Empowered Organic Method, or EOM™ as we call it, has now helped thousands of clients in hundreds of niches build profitable online course businesses… without burning out! Whether you want to help pay the bills, someday leave your 9-5, or eventually scale to 7-figures a year… I'm handing you the proven, plug-and-play process to truly move the needle in your business today! Check out her upcoming workshop HERE Don't forget to register for our upcoming FREE Content Creation Workshop here: https://www.thetimetogrow.com/content-creation-workshop-feb2024
Referencias: - Discurso: "La comprensión de nuestra verdadera identidad": https://www.churchofjesuschrist.org/study/general-conference/1998/04/understanding-our-true-identity?lang=spa#title1 - Sitio de FAIRMormon en el que niegan que José cometió un crimen al practicar la poligamia: https://www.fairlatterdaysaints.org/answers/Joseph_Smith/Polygamy/Illegal_in_Nauvoo - 1994, discurso de la conferencia, "no critiquen a los líderes": https://www.churchofjesuschrist.org/study/general-conference/1994/04/a-childs-love-matured?lang=spa - 2017, discurso de la conferencia, "criticar a los líderes es una debilidad": https://www.churchofjesuschrist.org/study/general-conference/2017/10/apart-but-still-one?lang=spa - 2023, discurso de la conferencia, "criticar a los líderes es letal para su fe": https://www.churchofjesuschrist.org/study/general-conference/2023/04/56corbitt?lang=spa - Uchtdorf, "la fe está por encima de la lógica": https://www.churchofjesuschrist.org/study/general-conference/2006/10/the-power-of-a-personal-testimony?lang=spa - Enciclopedia del mormonismo, "la fe y la ciencia nunca pueden estar en desacuerdo. Si lo están, la ciencia está mal": https://contentdm.lib.byu.edu/digital/collection/EoM/id/4169
In this week's issue Steroid and TNFα inhibitor treatments for uveitis may increase the risk of COVID-19 infection In a cross sectional survey of US adolescents, 25% had no vision testing within the past year Senile sclerotic optic disc damage had less visual field and optic disc progression compared with other forms of disc damage. Treatment with Tepezza significantly reduced EOM cross-sectional area in patients with thyroid eye disease
Bobby Green, MD, President and Chief Medical Officer at Thyme Care, Nashville, Tennessee, walks pharmacists through one of the most impactful payment models in oncology today, providing a natural break down of the enhancing oncology model (EOM) and how it works for patients and health care providers in Medicare and Medicaid.
In this episode of the Award-winning PRS Journal Club Podcast, 2023 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Ronnie Shammas- and special guest Rebecca W. Knackstedt, MD, PhD, discuss the following articles from the October 2023 issue: “A Comparative Study of Wraparound versus Anterior Coverage Placement of Acellular Dermal Matrix in Prepectoral Breast Reconstruction” by Han, Han, Eom, et al. Read the article for FREE: https://bit.ly/WraparoundADM Special guest Rebecca W. Knackstedt, MD, PhD, is a reconstructive microsurgeon at Duke University who specializes in breast reconstruction. She completed her residency training in the Cleveland Clinic followed by a microsurgery fellowship at the Cleveland Clinic as well. She's currently an attendee physician of Plastic Surgery at Duke University. READ the articles discussed in this podcast as well as free related content from the archives: https://bit.ly/JCOct23Collection #PRSJournalClub
Bret Keisling shares great ideas for celebrating Employee Ownership Month (EOM), including: company-wide parties that highlight company and employee owner milestones (don't forget the pie!); inviting elected officials and journalists to visit the company and its owners; arrange presentations by ESOP and co-op service providers to educate owners; and sponsoring contests to design posters, t-shirts, or even holiday and New Year's greeting cards with an employee ownership theme. Also, Bret shares highlights from EOM's origin. The former head of The ESOP Association (TEA), Michael Keeling, credits The National Center for Employee Ownership (NCEO) founder Corey Rosen with the idea and promoting it and turning it into the great celebration we have today. Is your company celebrating Employee Ownership Month? Let us know what you're doing. We'd love to share your events and successes on future episodes of the Podcast. Head to our website to read the transcript of this episode and get links to further resources: https://www.theesoppodcast.com/post/mini-cast-238-ideas-for-employee-ownership-month
Armed conflicts are ongoing around the world. At times it may seem that there are no rules in war. However, there are and they make a difference. "Even War Has Rules" is a dynamic discussion on international humanitarian law (IHL) and how it governs armed conflict. By the end of the hour, participants will achieve a general understanding of IHL and will be better able to evaluate the actions of parties to armed conflicts. Join Former Peace Corp Volunteer, Retired Teacher and Teacher-Trainer Joanne Dufour in learning international humanitarian law! Check out her blog: Disarming Our Planet ----------------- This event is hosted and sponsored by the International Services Department of the American Red Cross, Northwest Region. ***International Services offers a free service called Restoring Family Links, a program that helps reconnect families who have been separated by armed conflict, disaster, or other humanitarian crisis. International Humanitarian Law (IHL) -- See the video and ask questions of future guests at: www.theworldismycountry.com/club -- Music by: „World Citizen“ Jahcoustix feat. Shaggy courtesy of Dominik Haas, Telefonica and EoM Check out the film on World Citizen #1 Garry Davis at: www.theworldismycountry.com Also to endorse the ban on Nuclear Weapons go to: https://www.theworldismycountry.com/endorse
-- See the video and ask questions of future guests at: www.theworldismycountry.com/club -- Music by: „World Citizen“ Jahcoustix feat. Shaggy courtesy of Dominik Haas, Telefonica and EoM Also, check out the film on World Citizen #1 Garry Davis at: www.theworldismycountry.com
Bob and Liz run Story Connection, working in New Mexico with Native American Pueblo schools - and traveling the world telling stories -- that celebrate the intersection of myth, family and culture. Come hear how stories mold society and shape behavior -- and why stories are more powerful tools than facts and figures for influencing hearts and minds, shifting the paradigm and truly creating Social Change. Go to: storyconnection.com Bob and Liz developed Future Wave's BULLYPROOF program, engaging young people to use stories told through Puppet shows and a rap'n roll opera to learn powerful tools for handling conflict in more powerful ways than violence. At a time when world leaders are acting like schoolyard bullies, the world needs life-affirming stories -- and BULLYPROOF! -- See the video and ask questions of future guests at: www.theworldismycountry.com/club -- Music by: „World Citizen“ Jahcoustix feat. Shaggy courtesy of Dominik Haas, Telefonica and EoM Also, check out the film on World Citizen #1 Garry Davis at: www.theworldismycountry.com
With humanity poised at 90 seconds to doomsday, and growing risks of nuclear war breaking out with Russia, China & North Korea, we will be chatting with Medea Benjamin, co-founder of the Peace in Ukraine Coalition, about her new book "War in Ukraine: Making Sense of a Senseless Conflict". Nobel peace prize nominee Medea Benjamin is co-founder of the women-led peace group CODEPINK and of the human rights group Global Exchange. She is "one of America's most committed -- and most effective -- fighters for human rights" says NY Newsday and "one of the high profile leaders of the peace movement" says the Los Angeles Times. -- See the video and ask questions of future guests at: www.theworldismycountry.com/club -- Music by: „World Citizen“ Jahcoustix feat. Shaggy courtesy of Dominik Haas, Telefonica and EoM Also, check out the film on World Citizen #1 Garry Davis at: www.theworldismycountry.com
Happy Thursday! We start of the show congratulating everyone for being EOM, OSU hoops gets a transfer, Jarmo chats about the horrible CBJ season, Columbus likes to watch basketball, Panthers are slit on QB pick, we chat about the Masters & we do Would You Rather.
In this training, Jess is walking you through our unique EOM ™ formula so you can create a scalable 6-figure (and beyond) coaching business… without having a big following, paying for expensive ads, or burning out from hours on 1:1 calls. Most struggling entrepreneurs think that creating a business will give them freedom, but that couldn't be farther from the truth. It's actually systems & structure in your business that gives you freedom. Listen in as Jess breaks down the entire business machine, to ensure you're no longer acting as the machine. Live attendance is highly encouraged, and there will be special bonuses for those who attend each of the trainings live. However, if you're NOT able to join us live, don't worry - there will be a replay available to you for a limited time, so you can watch at a time that works for you. Catch the full replay right here on the DBE Youtube Channel: https://www.youtube.com/watch?v=w1--SgmKgPk Register for DBE Live Experience here: https://www.jessglazer.com/dbelive2023 As always, cheers to your evolution! Connect with Jess Instagram: @iamjessicaderose TikTok: @iamjessicaderose YouTube: Jessica DeRose
The OCM (Oncology Care Model), launched in 2016, is a payment model designed to help oncology centers transition from the traditional Medicare Fee-for-Service (FFS) payment structure and focus on high-value care.The EOM (Enhancing Oncology Model) is the next phase model and will replace OCM starting July 1, 2023. EOM will support clinicians caring for patients with seven common cancer types, focusing on health equity and accountable, affordable care.But what are the revenue-enhancing opportunities in EOM, is it worth the transition from OCM, and what does it actually provide?On today's episode of Technology and Oncology Podcast, host Michelle Dawn Mooney speaks with John Elliot, the Vice President of Sales at Carevīve to discuss how oncology centers and clinics can transition from OCM to EOM and how they can get assistance for the process.Michelle Dawn Mooney and John Elliot discussed:1. What clients should expect after approval and assistance available to meet the July 1 deadline for launching2. Benefits of EOM to oncology patients3. Where people can find more information and assistance on the topic“Looking at oncology, efficiency is key, however, there are limited constrained resources. 24/7 access to electronic records, having a line of communication, capturing symptoms at the right time, access to care with the focus of addressing challenges in the oncology and health care sector which can improve patient outcome and reduce cost – this is what the EOM aims to achieve. The EOM model bridges the gap of communication and ensures members of the care team are aware of what is happening in real-time, which promotes standardization of care,” explained John Elliot.John Elliot is the Vice President of Sales at Carevīve. He received his Bachelor of Arts degree in Advertising from Southern Methodist University and his Master of Business Administration from Washington University in St. Louis-Olin Business School. He has over ten years of experience working with oncology centers.
Education is a battleground for the hearts and minds of the future. The Church Education System of the Church of Jesus Christ of Latter-day Saints was founded in 1980, but the history of education in Mormonism is far more complex. We do a deep dive into how the CES started and the sordid pasts of the various educational institutions attached to the Church at some point. There's also a tangential deep dive into seminary and the legal sphere of “released time” classes carving out exemptions where religion can be taught in public schools. Then we discuss the modern battlefield of public education by reviewing the 2012 documentary, The Revisionaries, focused on public school text books and the fight at the Texas Board of Education. We round out with a quick overview of the best news of our lifetime, recommendations by the Jan 6th Committee to criminally indict the former POTUS for the violent insurrection at the federal capitol building in January 2021. CES history links: https://en.wikipedia.org/wiki/Church_Educational_System#cite_ref-E2014_3-2 https://digitalcommons.usu.edu/cgi/viewcontent.cgi?article=2184&context=etd&httpsredir=1&referer= https://www.churchofjesuschrist.org/church-education/about/ces-administration?lang=eng https://www.mormonwiki.com/Church_Educational_System https://mormonfaq.com/mormon-culture/about-education https://www.dialoguejournal.com/articles/the-founding-of-the-l-d-s-institutes-of-religion/ https://files.eric.ed.gov/fulltext/ED606970.pdf https://en.wikipedia.org/wiki/Horace_Mann https://en.wikipedia.org/wiki/Joseph_T._Kingsbury#cite_note-10 https://www.meforum.org/campus-watch/8306/aaup-1915-declaration-of-principles https://www.aaup.org/sites/default/files/files/University%20of%20Utah%20-%20December%201915.pdf https://archive.unews.utah.edu/news_releases/1915-a-year-that-changed-governance-tenure-and-academic-freedom-at-the-university-of-utah/ http://ldspioneerarchitecture.blogspot.com/p/blog-page.html https://contentdm.lib.byu.edu/digital/collection/EoM/id/5597 https://releasedtime.org https://www.mtsu.edu/first-amendment/article/884/released-time#:~:text=Released%20time%20programs%20allow%20for,hours%20to%20receive%20religious%20instruction. https://mtsu.edu/first-amendment/article/435/everson-v-board-of-education https://www.npr.org/2022/10/27/1131880548/football-coach-prayers-reinstated#:~:text=Bremerton%20High%20School.-,His%20practice%20of%20praying%20on%20the%20field%20sparked%20a%20court,religious%20expression%20in%20public%20schools.&text=The%20coach's%20insistence%20on%20praying,victory%20on%20religious%20freedom%20grounds. https://www.churchofjesuschrist.org/study/general-conference/1992/10/to-be-learned-is-good-if?lang=eng CES Purges: https://www.deseret.com/1995/3/30/19167147/feminist-club-at-byu-loses-its-voice-for-now https://universe.byu.edu/1996/03/14/voice-leader-chats/ https://universe.byu.edu/2001/06/01/feminist-voice-active-at-byu/ https://www.nytimes.com/1993/10/02/us/as-mormon-church-grows-so-does-dissent-from-feminists-and-scholars.html https://www.sltrib.com/religion/2022/11/28/byu-i-instructors-fired-failing/ https://newsroom.churchofjesuschrist.org/article/ecclesiastical-leader-questions-new-ces-hires MOGP: Revisionaries (2012): https://www.imdb.com/title/tt2091398/?ref_=nv_sr_srsg_1 FInd where it's streaming: https://www.justwatch.com/us/movie/the-revisionaries Happy news: Jan 6th committee filed report https://www.npr.org/2022/12/21/1144489935/january-6-committee-full-report-release https://apps.npr.org/documents/document.html?id=23515535-jan-6-select-committee-final-r Other Appearances: Come see us on Aron Ra's YouTube channel! He's doing a series titled Reading Joseph's Myth BoM. This link is for the playlist: https://www.youtube.com/playlist?list=PLXJ4dsU0oGMKfJKvEMeRn5ebpAggkoVHf Email: glassboxpodcast@gmail.com Patreon: https://www.patreon.com/GlassBoxPod Facebook page: https://www.facebook.com/glassboxpodcast Twitter: https://twitter.com/GlassBoxPod Instagram: https://www.instagram.com/glassboxpodcast/ Merch store: https://www.redbubble.com/people/exmoapparel/shop Or find the merch store by clicking on “Store” here: https://glassboxpodcast.com/index.html One time Paypal donation: bryceblankenagel@gmail.com
Teresa Caputo is one slippery sister! She must need the money because she is constantly failing in cold readings to cold audiences. Not one to be embarrassed by her own BS, Teresa carries on baiting false hope. Bryan wonders if she has started her own not-not for profit. She has all kinds of tricks of the trade to make herself appear supernatural. But Bryan and Krissy are not buying it. Take a listen as TCB breaks down another cold reading by Teresa! SBF is going to jail...after he gets out on bail Rumba's are taking pics of your boombas It's hard to get your morning movement in privacy when you have kids Kmart was a store once...it might still be a store somewhere? JC Penny is still hanging on by a thread Bryan use to be a JC Penny model 21 EOM stickers are on the way! Krissy forgets to remind herself to bring the notebook so she doesn't forget things! Season 3 has been a black hole of lost ideas Boxers or briefs? Your phone is listening to you! Teresa Caputo is back and failing right through a cold reading LINKS: Send us show ideas, comments, questions or concerns by texting us or leaving a voicemail at: 1.855.TCB.8383 Lululemon.com is for people who like comfort! Watch Us on YouTube Creator: Bryan Green Co-Host: Bryan Green Co-Host: Krissy Hoadley Written By: Bryan Green Exec Producers: Bryan Green & Krissy Hoadley Content Production & Research: Tina Khano YouTube Producer & Editor: Morgan Please Audio Editing: Christina A. Executive Director: Astrid B. Associate Producer: Gustavo Episodic Contribution: Marianne, Diane, Natalie, Will The Champ, Will D** Huge Thanks To Our Supportive Listeners, Friends, Family & Spouses: Astrid & Jeff!! Learn more about your ad choices. Visit podcastchoices.com/adchoices
Dr. Derek Raghavan, president of the Levine Cancer Institute at Atrium Health, and host Dr. John Sweetenham, of the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, predict the challenges oncologists will grapple with in 2023, including the cost-benefit of new treatments, how to retain the best talent, prioritizing health equity, and the future of home infusion for patients with cancer. TRANSCRIPT Dr. John Sweetenham: Hello, I'm John Sweetenham, the associate director for Clinical Affairs at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center, and host of the ASCO Daily News podcast. Today, I'm excited to welcome back Dr. Derek Raghavan, President of the Levine Cancer Institute at Atrium Health. And we'll be discussing some of the challenges that we anticipate are going to lie ahead for the oncology community in 2023. Our full disclosures are available in the transcript of this episode, and disclosures relating to all episodes of the ASCO Daily News podcast are available on our transcripts at: asco.org/podcasts. Derek, great to have you back on the podcast again today. Dr. Derek Raghavan: Thanks, John. Great to be back with you. Dr. John Sweetenham: One of the issues that we believe is going to be a challenge for us in the oncology world during the coming year that you and I have discussed on a previous podcast is this issue of cost benefits of new therapies in oncology, and the need to compare new treatments against old established standard of care treatments, rather than against the most recent new treatment preceding the one that we have now if you see what I'm saying. This is clearly going to be an ongoing concern. Why do you think we should be thinking about cost benefits of new treatments? And clearly, I think we'd all agree that this matters, but I think maybe you could expand a little on why you think it is truly important that we kind of go back and make sure we're comparing these drugs with the more established standards of care. Dr. Derek Raghavan: You know, I think this is sort of a metaphor of modern oncology, John, because it brings in so many elements. As you've implied, the cost of cancer care and not just cancer care, I mean it's all medical care just going through the roof, and unfortunately, it's happening most particularly in the United States. And whether that's just because here the pharmaceutical industry and government seem to have a very tight relationship, or whether there's some other explanation that is not clear, but I would make the comment that a lot of the newer treatments that are horrendously expensive in the United States, may be purchased for half the cost or less in other OECD countries. And that suggests that at some regulatory level, one of the parameters is a little off in the United States. And the reason that this is such a big deal is that it ultimately is hitting patients very hard. I think everyone has agreed, and we've discussed it in some detail in the past, everyone is identifying financial toxicity as becoming one of the governing toxicities of cancer care, and we've talked about strategies of dealing with that. As you implied, you know, we have this sort of tendency to think that anything new is wonderful, and anything old is terrible. And often, that's true. But I think the problem is that often, we will test the brand new agent of today with last year's brand new agent, which hasn't necessarily been fully tested at the time. So, if you think about prostate cancer, you know, the Michael Hofman group tested against cabazitaxel, and I'm not quite sure why cabazitaxel suddenly became the only drug to use second-line in prostate cancer. You know, doxorubicin has been there for a long time. Mitoxantrone has activity, even the old chestnut oral cytoxan has some activity there. And each of the drugs I've just mentioned is way cheaper than cabazitaxel. I'm not implying cabazitaxel is a bad drug, I'm simply saying it's more expensive. And I think as patients are really being harmed by the cost of care, I think one of the things that's kind of a shame, and it goes to the way we were trained, is oncologists have been trained not to think about the costs of what they're doing because the thought is that if we're thinking costs, we will withhold the best treatment because of cost considerations. I think the other side of that coin is we need to be thinking about what is the damage to patients that the cost is doing, and if there is substantial damage, is the patient getting that much bang for the buck? In other words, say an old cheap drug gives you three months extra survival, and a brand-new, very expensive drug gives you four months extra survival, do we really want to be thinking that that somehow is a wash and we should use the newer drug? At the very least, physicians should now be trained to have that discussion with patients and raise the issues so that patients aren't embarrassed by their inability to pay. We do know the two areas that are really hard to get patients to confess about, as it were, financial toxicity, and sexual dysfunction. And if we as physicians don't address that, we are going to be complicit in making these sorts of problems worse. So, one of the things is the costs of care. I think one of the other issues that is a little troubling is how we're thinking about new standards of care. There is a growth industry of consensus guidelines, and the reality is that some of the consensus guidelines, I think particularly, ASCO's, are very meticulously done. I've had the privilege of being part of a couple of the panels, and they were very rigorously driven, and they were trying to identify level-1 data and trying to be honest about outcomes. But some of the consensus guidelines are basically a bunch of good old boys getting together, and just chatting about what they do, and if they all do the same thing, then that becomes a guideline. And that can be a flawed approach, so that we've got consensus guidelines that are terrific, and some consensus guidelines that might be terrific, but may not be predicated on the best evidence. And then finally, one of my bugaboos is this sudden emphasis on real-world data. And I tend to worry about the concept of 'garbage in, garbage out'. A lot of the real-world analyses are either looking at databases that weren't designed for the way they're being implemented, or there are very practical reports of stuff that has happened, but without the necessary scientific rigor, such as considering what are the case selection biases that have led to those sets of real-world data being produced? So, that sort of compounds the problem of the fact that we need to be focusing a little more on, "What are we doing? Why are we doing it, and how robust are the data that support our patterns of practice?" One of the real leaders in this space is Mark Ratain, who's gone right back to torts and has started to ask questions about the pharmacology of drugs. There are dosing schedules that come out of phase I and phase II trials. There are often schedules that will be of benefit to the pharmaceutical industry but may not be fully evidence-based. So, you know, with a drug like Radium-223, which is for prostate cancer, it is said that you should give 6 doses. I'm unaware of any robust data that say that 6 is better than 5 is better than 4. Dr. John Sweetenham: Yeah. Thanks, Derek. Great responses. And I particularly like your insight into real-world evidence. I know that there have been attempts by ASCO, and by FDA, to put some parameters around real-world evidence, and get some, I guess you'd call it quality assurance into this, but I do agree with you that it's a little bit uncontrolled at the moment, and I think if we are going to continue to use these very, very large real-world datasets as a comparator, particularly, for drug approval, as well for studies, then there's probably still significant amount of work to be done to make sure that those data are collected in a consistent and rigorous fashion. Dr. John Sweetenham: I'm going to change gear now and talk, for just a little while, it's a huge subject and the time constraints will prevent us from saying too much about this, but of course, you know, health equity continues to be a major concern across healthcare in general, and in oncology specifically. We've now seen, for example, the replacement for the Oncology Care Model, The Enhancing Oncology Model, which has been proposed by CMMI. And not surprisingly, I think they recognize the need for addressing health equity and are introducing some health equity components into that in the next phase of Oncology Care Models from that group. But I guess my question at this point is, do you think that this kind of approach whereby health equity is at least to some extent addressed in the context of, for example, an alternative payment model, is the way ahead in terms of actually bringing about effective change, rather than just recording that there are indeed disparities? Dr. Derek Raghavan: So, that's a complex question, and I think there are several strands to the answer. I think the first thing I would say is, it really is time for us to recognize that we are at an inflection point. And we need to move from analysis paralysis to a new paradigm, which I would call, equity of survival. I have to say, I'm really over the multiple meetings that most of the professional societies have where people seem to feel good about saying, "Yep, we've come together and we've decided there really are disparities." We've known that there were disparities of care for probably 20 years, and some of us have done something about it and others haven't. But I think it's time to define equity of survival, and you can certainly do it. And what I mean by that is as follows: so, if I could use an example of a study from our place at the Levine Cancer Institute, Dr. Bei Hu, who is a very talented young lymphoma specialist, analyzed our outcomes for poorly insured, or uninsured, predominantly black American populations versus wealthy whites. And she published in Cancer and also presented prior to that at ASH, the fact that we had identical outcomes for diffuse large B-cell lymphoma; our hypothesis is that we were able to improve the results by using nurse navigation to help the underprivileged patients be able to adhere to the rigorous constraints of cuff management of diffuse large B-cell lymphoma. But you know, the fact is we are able to show that survival is the same in those two population groups. So, it isn't a question of, "Did you do more? Did you spend more time?" At the end of the day, the parameter is, they lived the same, and the quality of their lives, as we've measured, it was the same. So, I think that's one piece. I'm a bit negative about the government's new EOM. I've kept my institute out of the first OCM model because I thought that they were going to waste our time, and they played with it, and they learned very little, and then they generated a new model. I am very happy that there are health equity components in it, but of course, what we already know is government doesn't enforce those very well. If you look at the National Cancer Institute, and from my time on the parent committee and doing reviews, I was constantly saying, "But we aren't seeing the appropriate representation of minorities." Journal editors are still allowing the NCI-designated comprehensive cancer centers to publish papers with less than 5% Black Americans. And the argument is, "Oh, that's not in our demographic." But that's nonsense because the demographic of Black Americans and Hispanics in most parts of the United States are pretty well known, and the centers that I'm thinking about have perfectly large numbers of Black American, and Hispanic, and Native American patients. You know, I think there are two dimensions; one is government actually has to mean that they want to see things happen and enforce it appropriately, but at the same time, the idea that we're checking a box by doing yet another study of underserved populations where we're looking at demography, and their eating habits, and so on, when we're not concentrating on treatment-based survival. And the journal editors are turning down papers as being too descriptive when they report smaller studies of African American or Native American patients. All of those things have to be fixed, in my opinion. Dr. John Sweetenham: Great, thanks. And I'm going to change gear again to another issue, which, certainly, at our center is becoming more prominent for us, and that's an issue of sites of care. So, we are increasingly becoming aware that reimbursement issues are driving where our patients receive certain components of their care, particularly their chemotherapy. At the same time, we're also seeing increasing interest, I think partly fueled by the COVID-19 pandemic towards home treatment, and specifically, home infusion. So, I'd be interested to know where you think the future lies in terms of; number one, how you think this dynamic is going to play out around payers to some extent driving sites of care. And then secondly, what you see as the future of home infusion for cancer patients and potentially the use of home chemotherapy. Dr. Derek Raghavan: Well, you know, I tend, as you know well, to be one of your more cynical friends. I have real trouble with the insurance companies declaring publicly that they're struggling to keep up with the cost of treatment, and therefore they need to influence treatment when despite this incredibly difficult situation in which they find themselves, they're able to give seven and eight-figure bonuses to their Chief Executives every year. So, they're not doing poorly, they're just crying poor. And so, when they claim that they're doing things for the benefit of patients, I just don't believe that. So, the first thing is, the imperative to move care from point A to point B is driven by people with self-interest rather than necessarily trying to do it for patients. Now, having said that, I actually think COVID has taught us a lot. We can do many things very effectively through telemedicine, and for example, at the Levine Cancer Institute, we surveyed our patients who are dealing with the Supportive Oncology teams, Psycho-Behavioral Medicine, and Complementary Integrative Medicine. And so, they've actually shown us that they would prefer to have video consultation, which saves them having to get dressed, jump in the car, drive into the city, or to their local branch of LCI and so on. And so, there are demands where it's quite clear that patients like telemedicine and home care, and we know that because the cancellation rate of these appointments has gone way down with the introduction of telemedicine. So, for certain things, it's really good. You mentioned the concept of home infusion, and I think that's a terrific idea, provided that you have the necessary checks and balances. You and I both know that patients will suddenly crash with an allergic reaction in response to a drug like taxol and taxotere, or even sometimes, cisplatin, so, you don't want to have the situation where the nurse is infusing at home by herself, and trying to manage someone who's just shut down with an allergic reaction without any help. So, you need to have standard operating procedures that maximize life safety. Having said that, the idea of making it easier for patients to have their treatment and having it close to home is really, I think something that I really support. Where I'm less enthusiastic is something that the insurance companies have started to play with, and I believe ASCO is opposing this, at an organizational level, and that's the concept of white-bagging and brown-bagging. The idea that the insurance companies will somehow supervise the preparation and distribution of drugs to their satisfaction, and then expect oncologists or hospitals to take those drugs and administer them on their behalf. There is no clear evidence of quality control; it's absolutely clear that this is being done in a fashion that will allow them to control costs, and maybe not in an appropriate fashion. And I think that should be really strenuously opposed. Now, they're not the only culprits. What we have found is many of the largest centers declining to use biosimilars, for no particularly good reason, other than the fact that they're not that familiar with them. Well, there are good data to suggest that many of the biosimilars have equal efficacy and equal toxicity to the parent compounds, and they're way less costly. And so, we need to be thinking through a whole paradigm of, where are biosimilars available, what is the track record for their safety and utility, and so on. So, I think there are a number of steps that we can actually be involved in that will improve the cost of care. But doing it just because the insurance companies are trying to save themselves money may not be the primary driver that would influence my thinking. Dr. John Sweetenham: Yeah. Thanks, Derek. I'm interested in your comments on biosimilars because, you know, at our center, at UT Southwestern, we have certainly embraced biosimilar usage. And one of the points of care challenges in that regard is knowing which biosimilar is covered by an individual patient's insurance. And I know at a number of centers, that's been a challenge, and it's something that our pharmacy team has worked on in order to find a more facile way for our clinicians to be able to understand coverage. And there are significant cost savings associated with that. So, I agree 100% And talking of costs, the final issue which we wanted to talk with you about briefly today is the issue of prior authorization. Many ASCO members in the United States spend a very large amount of time dealing with this, and in the community oncology practice, it's estimated as much as 25% of an oncologist's time is now spent dealing with these issues, and obviously is very negative in terms of job satisfaction, physician burnouts, and so on, as well as just making things very, very difficult for our patients. Do you see a resolution to this? Do you think it will continue to be a big challenge, or do you think there are solutions available to us which will make this much easier for physicians, and save them some time as well as money? Dr. Derek Raghavan: No, I think it's here to stay. I mean, I think it's honestly multifactorial. I think it begins with government in the sense that we've just, once again, declared war on cancer. It's the third or fourth war that's been declared during my career, and that's all well and good. But you know, the reality is that that sets expectations in the community that can often be unrealistic. And so, that puts the unfortunate community, or academic oncologist in the situation of really struggling to say to a patient, "We've done what we can, and it's time to bring in supportive oncology or hospice." So, there are unrealistic expectations in the community. I think the second piece that relates to this is, the purveyors of computerized record systems are actually contributing more to burnout than probably anything else in the land. We've got unregulated industry where the service delivery for most of these companies is poor. And I think it all connects really with a broader issue, which is, for whatever reason, post-COVID, there is this phenomenon internationally of the so-called Great Resignation. It's partly burnout, it's partly anger about the world, I guess, at large. But what we are finding is, one of the pivotal areas for the Great Resignation is medical and nursing staff. I've never seen as many physicians retiring early, as many nurses getting out of oncology, and either going into the pharmaceutical industry or into data management or just going into simpler types of nursing. And that reflects the resistance of the healthcare industry to recognize that there are different stresses in different types and parts of the healthcare industry, and not compensating appropriately, and putting in safety valves to help these people get off the line. And you know, your question was, "Do I think it's here to stay?" I really do. I think the younger generation has, in many ways, a much more sensible approach to work-life balance than we did. They also have less experience. So, every time a crusty old veteran doctor, or nurse goes, they're replaced by someone with two decades less experience, and somewhat a different work ethic. I'm not saying it's a bad work ethic, but it's changing the way healthcare is delivered. So, I think this is going to be a real issue. And then finally, you know, in terms of the actual business of prior authorization, which I view largely as a tool that the health insurance companies use to avoid payment, I think we mentioned in a previous discussion on our financial toxicity tumor board, we have a pretty standard algorithm where we call the insurance companies before starting chemotherapy or radiotherapy; check in with them that their reading of their rules allows approval, and then we document who we spoke to, and what time. That seems to be quite a good way of stopping the insurance companies denying payment at a later time based on the technicality on page 253, line 27. While we're talking, John, what's happening at the Simmons Center and UT Southwestern? Are you seeing a change in the pattern of resignation of nurses and physicians, or have you managed to figure out strategies to avoid that? Dr. John Sweetenham: At UT Southwestern and Simmons Cancer Center, in particular, what we've seen is very similar, I think, to the national trends. And so, I think what we've seen is three main groups affected; our nursing staff, and as you say, I think there are various reasons why that's happened, our clinical trials staff, in particular, we've had an increasing problem in hiring and have lost many to industry actually. And then, on the physician front as well, we have seen a number of our physicians move to industry, both in terms of drug companies, and also some data companies where, you know, I think there is clearly an interest in having physician leadership. And, you know, I do agree with you, and I think part of the challenge, and there's been quite a lot of literature about this, as you'll know, is, what are we going to do, particularly in the academic oncology community, what are we going to do for our younger faculty in terms of growth opportunities for them that keep them within academic medicine? And I think we probably really have to rethink the way academic oncology is running at the moment if we're going to retain the best people within our field. So, a short answer to your question is, yeah, we're seeing very similar trends to those that are reported nationally. We're planning interventions, but obviously, all of these things take quite a long time. It's been great talking to you as always, Derek. I think it's good to hear your insights on the podcast, particularly, with respect to what might happen in 2023. I think as always, it's important to remember that despite the challenges, I think if you look back year-on-year, there is for sure, going to be a lot to be excited about this year. And our patients, I think, can anticipate to see continued improvements in what we do, and hopefully improvements in their lives and the lives of the caregivers who take care of them. So, despite the challenges, I think we need to just remember that it's not all bad, and there are a lot of good things going on out there. Dr. Derek Raghavan: Yeah, I agree with that, John. One of the things we always forget, despite the fact that you and I were tasked with talking about the problems emerging, is, the most rapidly growing patient population in oncology is the long-term survivors, and we can both be justifiably proud of all the good things that have happened to create that scenario. Dr. John Sweetenham: Absolutely. So, thanks, once again. Always a pleasure to talk with you. And to you, our listeners, thank you for your time today. If you value the insights that you hear on the ASCO Daily News podcast, please take a moment to rate, review, and subscribe, wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. John Sweetenham Dr. Derek Raghavan Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. John Sweetenham: Consulting or Advisory Role: EMA Wellness Dr. Derek Raghavan: Consulting or Advisory Role: Gerson Lehrman Group, Caris
As we gear up for Employee Ownership Month, we're sharing an interview on the history of EOM. In this episode, Bret Keisling was joined by Michael Keeling, retired head of The ESOP Association, who shares how Employee Ownership month started with The NCEO and blossomed into the EOM we love today. The full transcript of this episode, which includes links to all of the topics mentioned, is on our website at https://www.theesoppodcast.com/post/mini-cast-201-michael-keeling-the-origins-of-eom-icymi
The Center for Medicare & Medicaid Innovation has launched the Enhancing Oncology Model (EOM) to enhance the quality of care provided to cancer patients covered under Medicare Traditional while reducing Medicare fee-for-service expenditures, with nonbinding applications for the new program due by September 30, 2022. In this week's Sg2 Perspectives, we're joined by Sg2 Associate Principal Keely Macmillan who discusses the differences between EOM and the previous Oncology Care Model, why health care organizations should consider participating, and how EOM can assist with organizational health equity initiatives. Learn more about the Enhancing Oncology Model in Sg2's blog post and educational web series. We are always excited to get ideas and feedback from our listeners. You can reach us at sg2perspectives@sg2.com, find us on Twitter as @Sg2HealthCare, or visit the Sg2 company page on LinkedIn.
Quality cancer care is important to the well-being of cancer patients, and the government is working to increase the efficiency of care. In a recent Carevive podcast episode, host Michelle Dawn Mooney chatted with Carevive's Founder and Vice Chairman, Madelyn Herzfeld, about the Enhancing Oncology Model, or EOM. Through the Centers for Medicare and Medicaid Service (CMS) EOM, which is a replacement program for the phased-out OCM, or the Oncology Care Model, health providers have completed major improvements in cancer care in a cost-efficient way. Herzfeld, who is an oncology nurse, co-founded Carevive to revamp cancer care, and help cancer care providers meet their patient care goals. “We wanted to support clinicians and patients with tools that all aimed to improve quality — so improve the patient experience and get better quality and better clinical and financial outcomes,” said Herzfeld.With the end of OCM for EOM, Mooney and Herzfeld discussed the transition, and where organizations and providers are with the program's five-year timeline that will begin effective July 1, 2023. Herzfeld said CMS defined “specific care transformation activities result in better clinical outcomes for patients.”She added that the agency has generously funded a lot of practices that have participated in the program and made complete transformations to meet their guidelines. That often included patient care plans, survivorship care plans, and general quality care. Herzfeld also said the adjustments many practices incorporated have been a major encouragement in maintaining those changes and rejoining CMS's efforts. “So, for all of these practices that went through the test of time … they came back to CMS and were excited about all the changes that they had made based on this program and looking for what's next with everything that we've done. That's why CMS came out with this enhancing oncology model,” said Herzfeld.Carevive is a major supporter of practices in deciding on EOM, and the entirety of the process. The new model introduces electronic patient-reported outcomes and patient visit monitoring, as well as health-related social needs, stated Herzfeld. However, one challenge of the program is the performance-based payment model, which means good performance is awarded and performance that doesn't meet the mark translates into paying fees back.This could cost practices in the long run. Herzfeld says Carevive is attentive to that because money can create more problems for a practice trying to meet these targets. “I want to be sensitive of course to the oncology care team, administrators — all the cancer programs out there. They want to do the best job possible. Like all of us everything comes down to dollars and cents,” said Herzfeld.Of course, every practice might not feel that EOM is doable for them, and Herzfeld said that can come down to whether a practice decides to go with EOM or not. However, there are still other options. Herzfeld highly recommended that practices do prior data analysis research to help in their decision-making. EOM is likely not the ideal program for every practice, but in performing preliminary tasks, it can be a huge factor in the best outcome.“It just means there are other avenues to put these quality metrics into place, so I think just making educated decisions and having data to do that is really, really critical,” stated Herzfeld.
Quality cancer care is important to the well-being of cancer patients, and the government is working to increase the efficiency of care. In a recent Carevive podcast episode, host Michelle Dawn Mooney chatted with Carevive's Founder and Vice Chairman, Madelyn Herzfeld, about the Enhancing Oncology Model, or EOM. Through the Centers for Medicare and Medicaid Service (CMS) EOM, which is a replacement program for the phased-out OCM, or the Oncology Care Model, health providers have completed major improvements in cancer care in a cost-efficient way. Herzfeld, who is an oncology nurse, co-founded Carevive to revamp cancer care, and help cancer care providers meet their patient care goals. “We wanted to support clinicians and patients with tools that all aimed to improve quality — so improve the patient experience and get better quality and better clinical and financial outcomes,” said Herzfeld.With the end of OCM for EOM, Mooney and Herzfeld discussed the transition, and where organizations and providers are with the program's five-year timeline that will begin effective July 1, 2023. Herzfeld said CMS defined “specific care transformation activities result in better clinical outcomes for patients.”She added that the agency has generously funded a lot of practices that have participated in the program and made complete transformations to meet their guidelines. That often included patient care plans, survivorship care plans, and general quality care. Herzfeld also said the adjustments many practices incorporated have been a major encouragement in maintaining those changes and rejoining CMS's efforts. “So, for all of these practices that went through the test of time … they came back to CMS and were excited about all the changes that they had made based on this program and looking for what's next with everything that we've done. That's why CMS came out with this enhancing oncology model,” said Herzfeld.Carevive is a major supporter of practices in deciding on EOM, and the entirety of the process. The new model introduces electronic patient-reported outcomes and patient visit monitoring, as well as health-related social needs, stated Herzfeld. However, one challenge of the program is the performance-based payment model, which means good performance is awarded and performance that doesn't meet the mark translates into paying fees back.This could cost practices in the long run. Herzfeld says Carevive is attentive to that because money can create more problems for a practice trying to meet these targets. “I want to be sensitive of course to the oncology care team, administrators — all the cancer programs out there. They want to do the best job possible. Like all of us everything comes down to dollars and cents,” said Herzfeld.Of course, every practice might not feel that EOM is doable for them, and Herzfeld said that can come down to whether a practice decides to go with EOM or not. However, there are still other options. Herzfeld highly recommended that practices do prior data analysis research to help in their decision-making. EOM is likely not the ideal program for every practice, but in performing preliminary tasks, it can be a huge factor in the best outcome.“It just means there are other avenues to put these quality metrics into place, so I think just making educated decisions and having data to do that is really, really critical,” stated Herzfeld.
There is a need for hope and innovation in the delivery of value-based oncology care. Cancer costs are on an alarming trajectory due to the aging and growth of our population. Oncology is currently the 3rd most expensive specialty, but it is growing 3X faster than the top 3 specialties. Unless we find a way to replicate and scale value-based oncology care, it will be soon be the #1 most expensive specialty! Value-based transformation in oncology is especially needed due to the high variability in cancer costs from state-to-state, as we see a 2-3X cost differential multiple between regional markets, with no correlation between cost and quality. Eliminating cancer care disparities would prevent 34% of all deaths and save $230 billion in direct medical costs and $1 trillion in indirect costs to society. Furthermore, we are seeing financial toxicity in cancer care that results in 1 in 4 patients declaring bankruptcy within 2 years of diagnosis. And on top of that, 1 in 3 Medicare patients are refusing to fill lifesaving prescriptions due to high out-of-pocket costs. This financial toxicity in cancer care is disproportionately impacting minority and low income communities, leading to increased mortality, decreased quality of life, and lower survival rates. To find hope and innovation amidst these grim statistics, look no further than The Oncology Institute of Hope and Innovation (TOI). Their highly specialized, value-based cancer care practice delivers cutting-edge, evidence-based cancer care to a population of approximately 1.6 million patients. Oncology patients undergoing value-based care at TOI experience 40% fewer inpatient admissions, 75% fewer ER admissions, with patient satisfaction scores that are 14% higher than traditional oncology care. Joining us in the Race to Value this week is Brad Hively (CEO) and Dr. Daniel Virnich (President) from TOI – the largest oncology practices in the US. They discuss the importance of patient-centered high-quality, outcomes-based cancer care; emerging value-based oncology payment models; patient engagement and care coordination; clinical care pathways; physician compensation methodology; the importance of physician leadership in value transformation; and how to replicate growth at scale when delivery value-based oncology care. Episode Bookmarks: 01:30 Introduction to the Oncology Institute of Hope and Innovation (TOI), Brad Hively, and Dr. Dan Virnich 03:00 TOI is the first specialty value-based care company to go public (November 2021) and has become one of the largest oncology practices in the US 04:00 The unsustainable financial trajectory of American healthcare with annual costs of cancer care ballooning to $209 billion due to aging and growth of US population 06:00 “Oncology is the 3rd most expensive specialty in the senior population, but it is growing 3X faster than the top 3 specialties. It will soon be the #1 most expensive specialty.” 07:00 “From state-to-state, there can be a 2-3X multiple difference in oncology care costs, and there is no correlation between the cost and the quality.” 07:45 How do you replicate high value oncology markets across the country? (TOI is achieving 25% lower costs in oncology care.) 08:30 85%+ of oncology revenue comes from drugs (fee-for-service practices reimbursed at cost + 6% which creates a misalignment of financial incentives) 10:00 Medicare's new value-based Enhancing Oncology Model (EOM) that is replacing the Oncology Care Model (OCM) 11:30 Brad explains why the voluntary Oncology Care Model has not generated as much savings as Medicare initially envisioned. 12:30 Brad discusses TOI's participation outcomes in the OCM and how they are looking forward to EOM. 13:00 EOM will be slightly more limited (e.g. few cancer types included in the program, lower upfront care coordination payments). 14:00 The enhanced focus on health equity and patient navigation with the new EOM payment model.
Today we will be covering a devout method of hearing the Holy Sacrifice of the Mass taken from: The Ursuline Manual, or a Collection of Prayers, Spiritual Exercises Etc. Interspersed With The Various Instructions Necessary for Forming Youth to the Practice of Solid Piety Originally Arranged for the Young Ladies Educated at the Ursuline Convent, Cork. From the Beginning of Mass to the Gloria Divine Jesus ! Mediator of the New Testament I who didst ascend into heaven, to appear in the presence of God for us, (Heb. ix. 24.) yet daily descendest on our altars, to renew that sacrifice by which we were all redeemed, mercifully penetrate m y heart with a just sense of the happiness and the advantage of assisting at a sacrifice, by which I can abundantly satisfy the justice of God, honour his divine Majesty, acknowledge his infinite mercies, and obtain the graces necessary for serving him on earth and enjoying him in heaven. Permit me, O divine Jesus ! to ascend this new Calvary with thee, that my whole soul may do homage to the greatness of thy majesty; that my heart, with all its affections, may acknowledge thy infinite love; that my memory may dwell on the admirable mysteries here renewed; and that the sacrifice of my whole being may accompany that which thou art about to offer. Alas! I am unworthy to join with thy minister in adoring thee ; I can neither feel the extent of thy blessings, nor acknowledge them as I ardently desire to do; but, O Lord ! be thou with me, that by thee, and with thee, I may worthily assist at these tremendous mysteries. From the Gloria to the Epistle SAVIOUR of my soul! how sweet is the hope, that thou hast absolved me from my transgressions : that thy sacred blood has washed them away ; and that thou art about to seal my pardon by the most precious gift thou canst possibly bestow. DIVINE Lord ! let this encouraging hope be realized ; say to my soul, that thou art her salvation. With the fervent penitent of the gospel, I cast myself at thy sacred feet ; let me hear with her, from thy own adorable lips, the consolatory sentence of peace and mercy; let me experience with her, the conviction that thou hast accepted my repentance, and granted me pardon. Alas ! I well know that I have neither her humility nor her contrition, her fervour nor her love to offer ; but, my God ! I venture to say, that my hopes are established on still surer grounds than would be those virtues, were I happy enough to possess them. If many sins were pardoned her, because she loved thee much, still greater crimes will be remitted to me, because thou hast infinitely loved me, a wretched creature. adorable Jesus ! in thy love and mercy I firmly trust ; deign then to do for me what is altogether above my strength and capacity; purify my soul, and prepare it for the reception of thy life-giving sacrament. At the Epistle & Gospel I believe, my God! every article proposed by the holy Catholic Church to my belief; and through thy grace I am disposed to die, rather than relinquish the precious gift of faith, which elevates me to the adoption of the Sons of God, and makes me heir and joint-heir with Jesus Christ. Eom. viii. 15, 17. I believe; O divine Lord ! penetrate my heart and soul with the entire import of these short but comprehensive words, and let them produce one of those prodigies of grace and conversion, which so often followed from similar confessions. I believe all thou hast revealed, without exception or reserve ; for thou hast the words of eternal life, and thou art likewise the way and the truth, St. John, 30 xix. 6. On thy unerring word I also most firmly believe that thou art really present in the august sacrament of which I am about to participate. what miracles are contained in this sacred and ever adorable mystery ! Incomprehensible as they are, I believe them all ; I adore thy omnipotence, which is a sufficient pledge of their possibility ; and thy boundless love proves to me, in an endearing manner, that they are real. Were my faith as animated as I hope it is sincere, my heart would be inflamed at the near approach of its heavenly guest, and every movement of my body and soul would be a transport of gratitude and ardent love. Come, then, Lord! thou art the God in whom I firmly believe. Come, for thou art the support and term of my hope, and thou art, by excellence, the adorable object of my most fervent love. Come, enliven and increase in my soul the divine virtues infused therein on my admission into the bosom of thy Church. Come, and purify my baptismal robe, that I may present myself before thee with a nuptial garment, and may not deserve to be excluded from the marriage feast. Atthe Offertory Receive, Lord, this spotless Host, which thy minister offers thee in the name of thy Church. Receive, eternal Majesty, this oblation of bread and wine, which will soon become the body and blood of Jesus Christ, who, to render thee in the name of weak mortals the adoration thou meritest, vouchsafed to clothe himself with our miseries — to become susceptible of death, and to immolate himself daily on our altars as the precious victim of our salvation. omnipotent Lord ! behold me at thy feet loaded with miseries, and charged with innumerable debts, which would overwhelm me, were I not provided by thyself with a treasure of infinite value to acknowledge thy mercies, to satisfy thy justice, and to obtain for myself and others the graces thou desirest to bestow. Animated with the most lively confidence in the merits of my Redeemer, I offer thee once more his sufferings and death ; and I make this offering for the great ends for which he instituted this adorable mystery. I offer thee this sacred Victim to adore thee as my God, to testify my love for thee, my Sovereign Benefactor ! to thank thee for the blessings thou hast bestowed on all mankind ; to implore thy mercy on behalf of all those in a dreadful state of mortal sin, and to obtain the deliverance of the suffering souls in purgatory. To this offering: I unite an unreserved oblation of my whole being, and I desire to do so with the most generous and ardent love. I entreat thee, my God ! by the perfect oblation of my divine Saviour on the altar of the cross, to pardon my past ingratitude, and to grant me the inestimable grace of preservation from all mortal sin. But, my sovereign Benefactor ! how shall I thank thee for the precious gift of thy body and blood which thus enables me to satisfy my obligation! This gift, which the homage of angels and men would be insufficient to acknowledge, can only be repaid by itself. I then offer thee my Redeemer himself, as a sacrifice of praise, and pay my vows to thee, (Ps. cxv. 18,) in union with him in whom from all eternity thou wert well pleased. The Latin Prayer Podcast Patreon is finally up and running - for those of you who are able to financially support the podcast please Click Here (https://www.patreon.com/thelatinprayerpodcast). A huge thank you to my patrons! To follow me on other platforms Click on my LinkTree below. linktr.ee/dylandrego If you have any prayers you'd like to request, or comments and/or suggestions - please email me at latinprayerpodcast@gmail.com. Know that if you are listening to this, I am praying for you. Please continue to pray with me and for me and my family. May everything you do be Ad Majorem Dei Gloriam. God Love You! Valete (Goodbye)
Melanie Hearn is in the EOM house baby!!!!!! We're talking Juneteenth, Threesomes, Prince's women, and Melanie's men. Such a fun episode. Give it a listen AND a watch over on YouTube. Also introducing our new voice message link! Send us a joke, ask for advice, tell us you love us, and we'll respond live on the pod!! https://www.speakpipe.com/EachOthersMothers Produced by Marissa Roesch | Recorded at HMC Studios IG @eachothers.motherspod @johanna.medranda @connormedian @melaniejcomedy @mar.roes --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app
This week in the China Shop, Fed testimony and inflation revisions help add to the relief rally, while JPM predicts another 7% increase in equities ahead of EOM rebalancing. In Stock News, a ban on MO's Juul brand is paused for appeal and Kellog's announce a split into 3 separate companies. Over in the Crypto Corner, the Fed struggles to understand the SEC's decision on digital assets, while mining activity falls following the drop in values. With only one week left in this month's bet, a side bet makes things interesting, and Dan follows up with the long-awaited strip club interview.Check out the merch in our new shop here!If you like our show, please let us know by rating and subscribing on your platform of choice! Should you like our show and hate social media, then please tell all your friends!If you have no friends and hate social media and you just want to give us money for advertising and help you find more friends, then you can donate here!SponsorshipsOur podcast is sponsored by Sue Pullen at Fairway Independent Mortgage (MLS# 206048). Licensed in 25 states, if you need anything mortgage-related, reach out to her at SPullen@fairwaymc.com or give her a call at (520) 977-7904. Tell her 2 Bulls sent you to get the best rates available!If you are interested in signing up with TRADEPRO Academy, you can use our affiliate link here. We receive compensation for any purchases made when using this link, so it's a great way to support the show and learn at the same time! **Join our Discord for a link and code to save 10%**Check out the custom studies for futures trading over at OrderFlow Labs. We do not receive any compensation for referrals, we just love their community and tools!To contact us, you can email us directly at 2bulls@financialineptitude.com Or leave a message at (725) 22-BULLS. Be sure to follow us on Facebook, Twitter, or Discord to get updated when new content is posted! Links:Fed Speakers Ease Inflation WorriesConsumer Sentiment Survey Shows Inflation Expectations EasedFalling Copper Prices Indicating More Economic Trouble?JPM Predicting 7% Increase in Equities Next WeekFDA Jull Ban BlockedCharles Scharf Transforming Wells Fargo?Kellog's to Split into 3 CompaniesFed Evaluating SEC's Position on Digital AssetsElectricity Used to Mine Crypto PlummetsDiscord:https://discord.gg/Q8hft2zMTMLearn More Here***Send us your mailing address so we can send you a smash it yourself mug when you join!***Friends of the Show:TRADEPRO AcademyMindMuscles AcademyOrderFlow LabsBeginner Stuff:Beginner EpisodesKnowledge CenterResourcesAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
(not)Producer Marissa takes over to give you the top 5 most listened to episodes of EOM season 2 so far!! Johanna and Connor were out of town, so this is what you get :) Produced by Marissa Roesch | Recorded at HMC Studios IG @eachothers.motherspod @johanna.medranda @connormedian @mar.roes --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app
SHE'S BACK AND SHE'S STILL RLY HOT. Stella returns to EOM for possibly the most chaotic episode yet. Your hosts are hungover, Stella is drinking, there's a sugar daddy advertisement, and Stella almost met Flava Flav??? To quote the episode... "honey, I don't know." Give it a listen and give it a watch (youtube) pls & thnx. Produced by Marissa Roesch | Recorded at HMC Studios IG @eachothers.motherspod @johanna.medranda @connormedian @chnl.y2k @mar.roes --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app
Come hang out and play games with the EOM crew!!! No guest this week, but we're still fun. I swear. Send us some of your #GAYORSTRAIGHTGAME prompts on insta and we'll answer them on the pod :) Produced by Marissa Roesch | Recorded at HMC Studios IG @eachothers.motherspod @johanna.medranda @connormedian @mar.roes --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app
On this episode, Jay Jakub teaches how the biblical model of jubilee can be used as a basis for practicing capitalism more effectively. Dr. Jay Jakub is the Chief Advocacy Officer for the Economics of Mutuality Movement, which originated at Mars Incorporated. (A $40 billion company with 130k employees around the world, Mars is the maker of M&Ms, Snickers, and other iconic brands.) Jay and colleague Bruno Roches collaborated on the book Completing Capitalism: Heal Business to Heal the World, a rigorous and practical case study for the "Economics of Mutuality." In addition, this growing movement is now taught globally through Oxford University's Saïd Business School and elsewhere. His doctorate is in Modern History from Oxford University (St. John's College), and he has an M.A. in International Relations & Strategic Studies from the University of Lancaster (UK). www.EOM.org Theology of Business is the show for marketplace Christians seeking to explore and apply God's will for business. If you want to learn more about how to do business for the glory of God and shape culture through discipling the business world, this show is for you. | Entrepreneurship | Marketing | Nonprofit | Church | Author | Startups | Marketplace | Ministry | Business as Mission | Faith and Work | Faith | Success | Leadership | www.TheologyofBusiness.com
On this episode, Jay Jakub teaches how the biblical model of jubilee can be used as a basis for practicing capitalism more effectively. Dr. Jay Jakub is the Chief Advocacy Officer for the Economics of Mutuality Movement, which originated at Mars Incorporated. (A $40 billion company with 130k employees around the world, Mars is the maker of M&Ms, Snickers, and other iconic brands.) Jay and colleague Bruno Roches collaborated on the book Completing Capitalism: Heal Business to Heal the World, a rigorous and practical case study for the “Economics of Mutuality.” In addition, this growing movement is now taught globally through Oxford University's Saïd Business School and elsewhere. His doctorate is in Modern History from Oxford University (St. John's College), and he has an M.A. in International Relations & Strategic Studies from the University of Lancaster (UK). www.EOM.org Theology of Business is the show for marketplace Christians seeking to explore and apply God's will for business. If you want to learn more about how to do business for the glory of God and shape culture through discipling the business world, this show is for you. | Entrepreneurship | Marketing | Nonprofit | Church | Author | Startups | Marketplace | Ministry | Business as Mission | Faith and Work | Faith | Success | Leadership | www.TheologyofBusiness.com
WELCOME TO THE NEW EMPIRE BUILDER PODCAST!In honor of the last week of April, today's episode is all about how to CRUSH your EOM goals!If you love this episode, please take a screenshot and share it on your instagram and tag me @jordanenglishofficialThe Empire Builder Retreat is coming up! Get on the waitlist now to be the first to know when spots are available!GET ON THE RETREAT WAITLISTFollow Jordan on Instagram: instagram.com/jordanenglishofficial
© 2020-2025 Ivy Podcast Discovery LLC
